NSAIDs 1 - Understanding the clinical pharmacology of NSAIDs and its relevance to clinical practice Flashcards
How do NSAIDs reduce inflammation?
inhibit production of prostaglandins released by damaged tissue through inhibition of COX enzyme
Clinical indications - NSAIDs
- control pain in non-infectious/ non-allergenic inflammatory disorders (DJD, peri and post-op)
- Decrease platelet aggregation (thromboembolus, heartworm disease)
- Ophthalmology (rx of keratitis, scleritis, don’t inhibit corneal re-epithelialisation, intra-ocular sx as may minimise post-op increase protein content of AH).
- Some immunological diseases (SLE and RA, anti-inflammatory, may stimulate T suppressor cells in their action against T helper cells and auto-Ab producing BCs)
- endotoxic shock (LA only) but must be administered prior or immediately after onset of endotoxaemia with other supporive tx.
COX1 - actions
- produces prostaglandins important in physiological modulation of normal function:
- gut mucosal barrier
- intra-renal perfusion when renal BF decreased
What is COX-2 activated and released by?
- tissue damage
- bacterial lipopolysaccharide
- cytokines
- growth factors
- inflammation where PGE2 predominates
- important physiological functions (expressed constitutively in kidney macular densa to maintain renal perfusion by dilating afferent arteriole when vasoconstriction stimulated)
What is the COX1: COX2 ratio?
- ratio of effect varies with different drugs (why some are more ulcerogenic than others and other toxicity profiles)
- recent evidence shows the relative COX2 preference of a drug is influenced by the assay chosen, tissue type and species
What is the gold standard assay for COX profile of a drug?
whole blood assay
Outline carprofen specificity
- Dog = COX2 preferential (or non-selective)
- Horse = non-selective
- Cat = COX2 preferential (but significantly longer half-life than dog, daily dosing –> GIT disorder)
- Man = COX1 preferential
What is a non-specific COX inhibitor?
one with no meaningful or clinical differences in COX1 or 2 inhibition
COX2 inhibition - clinical benefits
Suppression of:
- inflammation
- pain
- fever (some)
- Alzheimer’s disease (this is an inflammatory process associated with COX2 increased expression, epidemiological studies suggest delayed expression and/or slow progression with NSAID use).
- Some cancers (colon, pancrease, lung, TCC, melanoma)
3 types of NSAID
- non-selective
- preferential (at least 2x greater inhibition of COX2 than -1 but usually 10-40)
- selective (>100 times selective for COX2)
Mechanisms of COX action
- inhibition of COX isoforms
- other actions at molecular levels peripherally and centrally (varies with drug)
- Many contribute to pharmacological, toxocological and therapeutic properties (5LO inhibition, prostaglandin-R blockade, scavenging free radicals, anti-bradykinin properties, inhibition of enzyme release or action, inhibition of cytokine release, inhibition of NFkB)
Pharmacodynamics - COX
usually expressed as IC50 values
Assay methods - COX assay
- cell based
- tumour cell lines
- whole blood (gold standard)
How is COX1 inhibitory activity detected?
inhibition of clot-induced thromboxane B2 production
How is COX2 inhibitory activity detected?
inhibition of LPS induced PGE2 production
What may influence safety of NSAIDs?
- degree of acidity of the pro-drug (direct gastric mucosal damage)
- plasma half life
- degree of enterohepatic recycling
Therapeutic aim - NSAIDs
- > 80% inhibition of COX2 (for p art though not all of 24hr)
- COX1 inhibition should be
Examples - non-selective COX inhibitors
- aspirin
- phenylbutazone
- ketoprofen
- tolfenamic acid
Outline preferential COX-2 inhibitors
- 2 to 40 x more selective for COX2
- analgesic and anti-inflam. at doses that inhibit COX2 but not COX1
- some COX1 inhibition at elevated or therapeutic dosages
- includes drugs classes as coxibs
Examples - preferential inhibitors of COX2 (dog, cat)
- meloxicam
- Carprofen
- Mavacoxib
- Cimicoxib (probably)
- Deracoxib (USA and Australia)
Examples - UK selective inhibitors of COX2
- firocoxib
- robenocoxib